Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOBRAMYCIN vs TOCILIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOBRAMYCIN vs TOCILIZUMAB: Safety Overview

Metric TOBRAMYCIN TOCILIZUMAB
Total FAERS Reports 11,597 98,443
Deaths Reported 1,306 9,543
Death Rate 11.3% 9.7%
Hospitalizations 5,106 24,039
Average Patient Age 38.0 yrs 52.2 yrs
% Female Patients 54.0% 84.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Lifestar Pharma LLC CELLTRION USA, Inc.
Route RESPIRATORY (INHALATION) INTRAVENOUS
Marketing Status Discontinued Prescription